Hero or Villain – Are SGLT2 Inhibitors Your Patients’ BFF or Something to Be Cautious Of?
Lessons from Current Guidelines and ASN
Speakers: Professor Sophia Zoungas, Professor Carmel Hawley, Professor Karen Dwyer, Dr Brendan Smyth and Dr Melinda Tee
Date: 18 November 2021